Forgot Password

Flat 25% discount on all reports exclusively for July & August 2018

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Diagnostics » HME-1491015
  • Global Allergy Diagnostics and Treatments Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Publish: November 2016 | Report Code: HME-1491015

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Global Allergy Diagnostics and treatment market is expected to have the CAGR of 12.67% in the forecast period 2016-2023.  The major factors driving the global allergy diagnostics and treatment market are increasing number of allergies, rising IVD market, increasing healthcare expenditure and increasing laboratory automation. Increasing respiratory allergic cases day by day has increased the market of allergy diagnostics and treatment. According to American Academy of Allergy Asthma and Immunology (AAAAI), in 2016, around 7.8 million children suffered from respiratory allergies worldwide. Food allergies and eczema are the most common chronic non-communicable diseases in children in several countries. The adoption of allergy diagnostics and treatment in global allergy diagnostics and treatment market is driven by following factors:

  • Increasing Allergies
  • Growing IVD Market
  • Increasing Healthcare Expenditure
  • Increasing Laboratory Automation





Increasing strict regulations for the approval and use of the medial devices is the major factor hindering the growth of allergy diagnostics and treatment market. Regulations are formulated to strengthen the supervision, administration of medical devices and ensuring their safety and effectiveness and protection against human health and life safety. The medical devices are defined by the regulations which refer to any material, appliance, apparatus, instrument or other article whether used alone or in combination, including software which is used in that proper application. It does not achieve its principal action in or on the human body by means of metabolism, immunology or pharmacology. Approval for the trial of new devices from any of the relevant authority is quite compulsory so as to use the product. The drug regulatory authorities of government appoint medical device monitors in their organization, who are responsible for the supervision of medical device manufacturing enterprises, distribution enterprises and medical institutions within their own administrative regions.   In the case when the medical devices are manufactured without any product registration certificates, then the drug regulatory authority of government shall issue an order to stop the production, confiscate all the illegal manufactured products and related illegal income.

Source: OBRC Analysis

Global allergy diagnostics and treatment market is majorly segmented on the basis of types, product and end users. On the basis of types, the allergy diagnostics and treatment market is further segmented as:

  • Food
  • Inhaled
  • Others




On the basis of product, the allergy diagnostics and treatment market is further segmented as:

  • Assay Kits
  • Consumables
  • Instruments



On the basis of end users, the allergy diagnostics and treatment market is further segmented as:

  • Academic Research Centres
  • Diagnostic Laboratories
  • Hospitals
  • Other





The revenue for the above types, products and end-user segment are specific to the allergy diagnostics and treatment market. However, the total revenue of these products, type and end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up product, type and end-user segment.

Geographically, global allergy diagnostics and treatments market is segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America holds the largest market share of allergy diagnostics and treatment and is followed by Europe. High technology and high investments in medical sector is helping the market to grow. In addition to this, every thirteen children of age 18 years in U.S. suffers from at least one of the allergic problems. In Europe, there are more than 17 million cases of food allergy and there has been a seven times increase among children over the past decades. Moreover, Asian Pacific market is expected to rise rapidly at a high CAGR in the forecast period, due to the rapid increase in the geriatric population, and large untapped potential of these markets. However, based on end user segment, hospitals dominates the market and it is expected to grow in the future.

The major market players of the global allergy diagnostics and treatment market are:

  • ALLERCHECK LABORATORIES INC.
  • BIOMERIEUX SA
  • DANAHER CORPORATION
  • STALLERGENES
  • OTHERS






Detailed analysis of these companies provided in this report comprises of overview, SCOT analysis, product portfolio, strategic initiative and strategic analysis.

These companies use various strategies such as merger & acquisition, collaboration, partnership and product launching. Acquisitions and mergers are the key strategies adopted by the market players to sustain in the market. For example: MeDALL allergen chip is used to determine allergies which enhance allergy diagnostics and treatment market globally. In Japan 2015, Stallergenes received approval for STG 320 which is the first tablet used in the treatment of allergies against house dust mite.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as acquisition that is on April 2016, Siemens Healthcare acquires San-Francisco based company Medicalis Corporation so as expand the tools it can offer health systems and hospitals to manage value-based care.
  • Provide in detail the different segments such as products and end-users which affect the global allergy diagnostics and treatment market.
  • Provide you the patent analysis of global allergy diagnostics and treatment market.
  • Identify and understand the strengths, opportunities, challenges and threats of global allergy diagnostics and treatment market.
  • Provide revenues of major players of the market such as Danaher Corporation and Hitachi Chemical Diagnostics, Inc.
  • Provide you various regulatory policies which affect the global allergy diagnostics and treatment market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global allergy diagnostics and treatment market offers the longest chain of market segmentation covering major market segmentation based on products and end users. The report tracks the major market trends in the global allergy diagnostics and treatmentmarket such as rising availability of effective treatment options.   For each market segments covered in global allergy diagnostics and treatment market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the allergy diagnostics and treatment industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, see saw analysis, and porter five force model and so on. For the high-level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global allergy diagnostics and treatment market:

  • North America had the largest revenue share in 2016.
  • Based on product Assay Kit dominates the market.
  • Acquisition is the key strategy adopted by the various market players of global allergy diagnostics and treatment market.
  • Hospital is the major segment of end user.

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL  ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET : EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1.        TOP 5 FINDINGS

2.5.2.        TOP 5 OPPORTUNITY MARKETS

2.5.3.        TOP 5 COMPANIES

2.5.4.        TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1.        INVESTMENT VS. ADOPTION MODEL

2.7.2.        360-DEGREE INDUSTRY ANALYSIS

2.7.3.        PORTERS 5 FORCE MODEL

2.7.4.        SEE-SAW ANALYSIS

2.7.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1.        KEY STRATEGIES & ANALYSIS

2.8.2.        MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        INCREASING PREVALENCE OF ALLERGIC DISEASES

3.1.2.        GROWING IVD MARKET

3.1.3.        INCREASING HEALTHCARE EXPENDITURE

3.1.4.        INCREASING ACCESS FOR ALLERGY DIAGNOSIS MEDICAL INSURANCE IN THE US

3.2. MARKET RESTRAINTS

3.2.1.        LOW AWARENESS OF ALLERGIC DISEASES

3.2.2.        AFFORDABILITY ISSUES OF ALLERGY DIAGNOSTICS INSTRUMENTS

3.3. MARKET OPPORTUNITIES

3.3.1.        INCREASING OPPORTUNITIES IN DEVELOPING COUNTRIES

3.4.   MARKET CHALLENGES

3.4.1.        HIGH TURNAROUND TIME

3.4.2.        GROWTH IN THE NUMBER OF REAGENT RENTAL AGREEMENTS

4.      GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.  OPPORTUNITY MATRIX

4.5. MARKET SEGMENTATION

4.5.1.      GLOBAL DIAGNOSTICS MARKET

4.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3.  KEY PLAYERS & KEY PRODUCTS

4.5.1.4.  KEY CONCLUSIONS

4.5.2.      GLOBAL TREATMENT MARKET

4.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3.  KEY PLAYERS & KEY PRODUCTS

4.5.2.4.  KEY CONCLUSIONS

4.5.3.      GLOBAL IMMUNOTHERAPY MARKET

4.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.3.3.  KEY PLAYERS & KEY PRODUCTS

4.5.3.4.  KEY CONCLUSIONS

5.      GLOBAL ALLERGY DIAGNOSTICS MARKET BY  TYPE

5.1. MARKET DEFINITION AND SCOPE

5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4.  OPPORTUNITY MATRIX

5.5. MARKET SEGMENTATION

5.5.1.      GLOBAL SKIN PRICK, PATCH INTRADERMAL TEST MARKET

5.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.3.  KEY PLAYERS & KEY PRODUCTS

5.5.1.4.  KEY CONCLUSIONS

5.5.2.      GLOBAL ANTIBODY MARKET

5.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3.  KEY PLAYERS & KEY PRODUCTS

5.5.2.4.  KEY CONCLUSIONS

6.      GLOBAL ALLERGY TREATMENT MARKET BY  TYPE

6.1. MARKET DEFINITION AND SCOPE

6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.4.  OPPORTUNITY MATRIX

6.5. MARKET SEGMENTATION

6.5.1.      GLOBAL PRESCRIPTION MARKET

6.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.1.3.  KEY PLAYERS & KEY PRODUCTS

6.5.1.4.  KEY CONCLUSIONS

6.5.2.      GLOBAL GENERIC MARKET

6.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.2.3.  KEY PLAYERS & KEY PRODUCTS

6.5.2.4.  KEY CONCLUSIONS

6.5.3.      GLOBAL OTC  MARKET

6.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.3.3.  KEY PLAYERS & KEY PRODUCTS

6.5.3.4.  KEY CONCLUSIONS

7.      GLOBAL ALLERGY TREATMENT MARKET BY FORM OF ADMINISTRATION

7.1. MARKET DEFINITION AND SCOPE

7.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

7.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

7.4.  OPPORTUNITY MATRIX

7.5. MARKET SEGMENTATION

7.5.1.      GLOBAL ORAL MARKET

7.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.5.1.3.  KEY PLAYERS & KEY PRODUCTS

7.5.1.4.  KEY CONCLUSIONS

7.5.2.      GLOBAL TOPICAL MARKET

7.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.5.2.3.  KEY PLAYERS & KEY PRODUCTS

7.5.2.4.  KEY CONCLUSIONS

7.5.3.      GLOBAL SPRAY MARKET

7.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.5.3.3.  KEY PLAYERS & KEY PRODUCTS

7.5.3.4.  KEY CONCLUSIONS

7.5.4.      GLOBAL OCULAR MARKET

7.5.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.5.4.3.  KEY PLAYERS & KEY PRODUCTS

7.5.4.4.  KEY CONCLUSIONS

8.      GLOBAL ALLERGY TREATMENT MARKET BY TREATMENT PRODUCTS

8.1. MARKET DEFINITION AND SCOPE

8.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

8.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

8.4.  OPPORTUNITY MATRIX

8.5. MARKET SEGMENTATION

8.5.1.      GLOBAL ANTIHISTAMINES  MARKET

8.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.1.3.  KEY PLAYERS & KEY PRODUCTS

8.5.1.4.  KEY CONCLUSIONS

8.5.2.      GLOBAL SYMPATHOMIMETICS DECONGESTANTS AND COMBINATIONS MARKET

8.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.2.3.  KEY PLAYERS & KEY PRODUCTS

8.5.2.4.  KEY CONCLUSIONS

8.5.3.      GLOBAL CORTICOSTEROIDS MARKET

8.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.3.3.  KEY PLAYERS & KEY PRODUCTS

8.5.3.4.  KEY CONCLUSIONS

8.5.4.      GLOBAL LEUKOTRIENESMARKET

8.5.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.4.3.  KEY PLAYERS & KEY PRODUCTS

8.5.4.4.  KEY CONCLUSIONS

8.5.5.      GLOBAL MAST CELL STABILIZERS MARKET

8.5.5.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.5.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.5.3.  KEY PLAYERS & KEY PRODUCTS

8.5.5.4.  KEY CONCLUSIONS

9.      GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  STAKEHOLDERS

9.1. MARKET DEFINITION AND SCOPE

9.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

9.3. MARKET SEGMENTATION

9.3.1.      GLOBAL RETAILERS MARKET

9.3.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

9.3.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.3.2.      GLOBAL RAW MATERIAL SUPPLIER MARKET

9.3.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

9.3.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.3.3.      GLOBAL MANUFACTURER MARKET

9.3.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

9.3.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.3.4.      GLOBAL DISTRIBUTOR AND LOGISTICS MARKET

9.3.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

9.3.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.   COMPETITIVE LANDSCAPE

10.1.                  KEY STRATEGIES

10.1.1.   LIST OF MERGERS AND ACQUISITION

10.1.2.   LIST OF JOINT VENTURES

10.1.3.   LIST OF PRODUCT LAUNCHES

10.1.4.   LIST OF PARTNERSHIPS

11.   GEOGRAPHIC ANALYSIS

11.1.                  DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

11.2.                  COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

11.3.                  OPPORTUNITY MATRIX

11.4.                  GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY REGION 2015-2024 ($ MILLION)

11.4.1.  NORTH AMERICA

11.4.1.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

11.4.1.2.                      TOP COUNTRY ANALYSIS

11.4.1.2.1.  U.S.

11.4.1.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.1.2.1.2.           KEY PLAYERS & KEY PRODUCTS

11.4.1.2.1.3.           KEY CONCLUSIONS

11.4.1.2.2.  CANADA

11.4.1.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.1.2.2.2.           KEY PLAYERS & KEY PRODUCTS

11.4.1.2.2.3.           KEY CONCLUSIONS

11.4.2.  EUROPE

11.4.2.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

11.4.2.2.                      TOP COUNTRY ANALYSIS

11.4.2.2.1.  UK

11.4.2.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.2.2.1.2.           KEY PLAYERS & KEY PRODUCTS

11.4.2.2.1.3.           KEY CONCLUSIONS

11.4.2.2.2.  FRANCE

11.4.2.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.2.2.2.2.           KEY PLAYERS & KEY PRODUCTS

11.4.2.2.2.3.           KEY CONCLUSIONS

11.4.2.2.3.  GERMANY

11.4.2.2.3.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.2.2.3.2.           KEY PLAYERS & KEY PRODUCTS

11.4.2.2.3.3.           KEY CONCLUSIONS

11.4.2.2.4.  SPAIN

11.4.2.2.4.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.2.2.4.2.           KEY PLAYERS & KEY PRODUCTS

11.4.2.2.4.3.           KEY CONCLUSIONS

11.4.2.2.5.  REST OF EUROPE

11.4.2.2.5.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.2.2.5.2.           KEY  PLAYERS & KEY PRODUCTS

11.4.2.2.5.3.           KEY CONCLUSIONS

11.4.3.  ASIA PACIFIC

11.4.3.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

11.4.3.2.                      TOP COUNTRY ANALYSIS

11.4.3.2.1.  CHINA

11.4.3.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.3.2.1.2.           KEY PLAYERS & KEY PRODUCTS

11.4.3.2.1.3.           KEY CONCLUSIONS

11.4.3.2.2.  INDIA

11.4.3.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.3.2.2.2.           KEY PLAYERS & KEY PRODUCTS

11.4.3.2.2.3.           KEY CONCLUSIONS

11.4.3.2.3.  JAPAN

11.4.3.2.3.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.3.2.3.2.           KEY PLAYERS & KEY PRODUCTS

11.4.3.2.3.3.           KEY CONCLUSIONS

11.4.3.2.4.  AUSTRALIA

11.4.3.2.4.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.3.2.4.2.           KEY  PLAYERS & KEY PRODUCTS

11.4.3.2.4.3.           KEY CONCLUSIONS

11.4.3.2.5.  REST OF ASIA PACIFIC

11.4.3.2.5.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.3.2.5.2.           KEY  PLAYERS & KEY PRODUCTS

11.4.3.2.5.3.           KEY CONCLUSIONS

11.4.4.  ROW

11.4.4.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

11.4.4.2.                      TOP COUNTRY ANALYSIS

11.4.4.2.1.  LATIN AMERICA

11.4.4.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.4.2.1.2.           KEY PLAYERS & KEY PRODUCTS

11.4.4.2.1.3.           KEY CONCLUSIONS

11.4.4.2.2.  MIDDLE EAST & AFRICA

11.4.4.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.4.2.2.2.           KEY PLAYERS & KEY PRODUCTS

11.4.4.2.2.3.           KEY CONCLUSIONS

12.   COMPANY PROFILES

12.1.                  ALCON LABORATORIES (U.S.)

12.1.1.   OVERVIEW

12.1.2.   PRODUCT PORTFOLIO

12.1.3.   STRATEGIC INITIATIVES

12.1.4.   SCOT ANALYSIS

12.1.5.   STRATEGIC ANALYSIS

12.2.                  ALERCHECK, INC. (U.S.)

12.2.1.   OVERVIEW

12.2.2.   PRODUCT PORTFOLIO

12.2.3.   STRATEGIC INITIATIVES

12.2.4.   SCOT ANALYSIS

12.2.5.   STRATEGIC ANALYSIS

12.3.                  ASTRA BIOTECH (GERMANY)

12.3.1.   OVERVIEW

12.3.2.   PRODUCT PORTFOLIO

12.3.3.   STRATEGIC INITIATIVES

12.3.4.   SCOT ANALYSIS

12.3.5.   STRATEGIC ANALYSIS

12.4.                  BIOMERIEUX (FRANCE)

12.4.1.   OVERVIEW

12.4.2.   PRODUCT PORTFOLIO

12.4.3.   STRATEGIC INITIATIVES

12.4.4.   SCOT ANALYSIS

12.4.5.   STRATEGIC ANALYSIS

12.5.                  DANAHER CORPORATION (U.S.)

12.5.1.   OVERVIEW

12.5.2.   PRODUCT PORTFOLIO

12.5.3.   STRATEGIC INITIATIVES

12.5.4.   SCOT ANALYSIS

12.5.5.   STRATEGIC ANALYSIS

12.6.                  HITACHI CHEMICAL DIAGNOSTICS (U.S.)

12.6.1.   OVERVIEW

12.6.2.   PRODUCT PORTFOLIO

12.6.3.   STRATEGIC INITIATIVES

12.6.4.   SCOT ANALYSIS

12.6.5.   STRATEGIC ANALYSIS

12.7.                  HOB BIOTECH GROUP (CHINA)

12.7.1.   OVERVIEW

12.7.2.   PRODUCT PORTFOLIO

12.7.3.   STRATEGIC INITIATIVES

12.7.4.   SCOT ANALYSIS

12.7.5.   STRATEGIC ANALYSIS

12.8.                  HYCOR BIOMEDICAL (U.S.)

12.8.1.   OVERVIEW

12.8.2.   PRODUCT PORTFOLIO

12.8.3.   STRATEGIC INITIATIVES

12.8.4.   SCOT ANALYSIS

12.8.5.   STRATEGIC ANALYSIS

12.9.                  LINCOLN DIAGNOSTICS (U.S.)

12.9.1.   OVERVIEW

12.9.2.   PRODUCT PORTFOLIO

12.9.3.   STRATEGIC INITIATIVES

12.9.4.   SCOT ANALYSIS

12.9.5.   STRATEGIC ANALYSIS

12.10.              OMEGA DIAGNOSTICS (UK)

12.10.1.                       OVERVIEW

12.10.2.                       PRODUCT PORTFOLIO

12.10.3.                       STRATEGIC INITIATIVES

12.10.4.                       SCOT ANALYSIS

12.10.5.                       STRATEGIC ANALYSIS

12.11.              R-BIOPHARM AG (GERMANY)

12.11.1.                       OVERVIEW

12.11.2.                       PRODUCT PORTFOLIO

12.11.3.                       STRATEGIC INITIATIVES

12.11.4.                       SCOT ANALYSIS

12.11.5.                       STRATEGIC ANALYSIS

12.12.              SANOFI S.A (FRANCE)

12.12.1.                       OVERVIEW

12.12.2.                       PRODUCT PORTFOLIO

12.12.3.                       STRATEGIC INITIATIVES

12.12.4.                       SCOT ANALYSIS

12.12.5.                       STRATEGIC ANALYSIS

12.13.              SIEMENS HEALTHCARE (GERMANY)

12.13.1.                       OVERVIEW

12.13.2.                       PRODUCT PORTFOLIO

12.13.3.                       STRATEGIC INITIATIVES

12.13.4.                       SCOT ANALYSIS

12.13.5.                       STRATEGIC ANALYSIS

12.14.              STALLERGENES (UK)

12.14.1.                       OVERVIEW

12.14.2.                       PRODUCT PORTFOLIO

12.14.3.                       STRATEGIC INITIATIVES

12.14.4.                       SCOT ANALYSIS

12.14.5.                       STRATEGIC ANALYSIS

12.15.              THERMO FISHER SCIENTIFIC (U.S.)

12.15.1.                       OVERVIEW

12.15.2.                       PRODUCT PORTFOLIO

12.15.3.                       STRATEGIC INITIATIVES

12.15.4.                       SCOT ANALYSIS

12.15.5.                       STRATEGIC ANALYSIS

LIST OF TABLES

1.       GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY TYPE  2015-2024 ($ MILLION)

2.       GLOBAL DIAGNOSTICS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL TREATMENT  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL  IMMUNOTHERAPY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5.       GLOBAL ALLERGY DIAGNOSTICS MARKET BY TYPE  2015-2024 ($ MILLION)

6.       GLOBAL SKIN PRICK, PATCH INTRADERMAL TEST MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

7.       GLOBAL ANTIBODY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

8.       GLOBAL ALLERGY TREATMENTS MARKET BY TYPE  2015-2024 ($ MILLION)

9.       GLOBAL  PRESCRIPTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL GENERIC MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL OTC MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

12.   GLOBAL ALLERGY TREATMENTS MARKET BY FORM OF ADMINISTRATION 2015-2024 ($ MILLION)

13.   GLOBAL ORAL MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

14.   GLOBAL  TOPICAL MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

15.   GLOBAL SPRAY MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

16.   GLOBAL  OCULAR MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

17.   GLOBAL ALLERGY TREATMENTS MARKET BY TREATMENT PRODUCTS 2015-2024 ($ MILLION)

18.   GLOBAL  ANTIHISTAMINES  MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

19.   GLOBAL SYMPATHOMIMETICS DECONGESTANTS AND COMBINATIONS  MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

20.   GLOBAL  CORTICOSTEROIDS MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

21.   GLOBAL LEUKOTRIENES MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

22.   GLOBAL  MAST CELL STABILIZERS MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

23.   GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY STAKEHOLDERS 2015-2024 ($ MILLION)

24.   GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

25.   NORTH AMERICA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

26.   EUROPE ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET 2015-2024 ($ MILLION)

27.   ASIA PACIFIC ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

28.   REST OF THE WORLD ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

29.   NORTH AMERICA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

30.   EUROPE ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET BY  TYPE 2015-2024 ($ MILLION)

31.   ASIA PACIFIC ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

32.   REST OF THE WORLD ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

33.   NORTH AMERICA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

34.   EUROPE ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

35.   ASIA PACIFIC ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

36.   REST OF THE WORLD ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

37.   NORTH AMERICA ALLERGY TREATMENT MARKET BY  TYPE 2015-2024 ($ MILLION)

38.   EUROPE ALLERGY TREATMENT MARKET BY  TYPE 2015-2024 ($ MILLION)

39.   ASIA PACIFIC ALLERGY TREATMENT MARKET BY  TYPE 2015-2024 ($ MILLION)

40.   REST OF THE WORLD ALLERGY TREATMENT MARKET BY  TYPE 2015-2024 ($ MILLION)

41.   NORTH AMERICA ALLERGY TREATMENT MARKET BY FORM OF ADMINISTRATION 2015-2024 ($ MILLION)

42.   EUROPE ALLERGY TREATMENT MARKET BY FORM OF ADMINISTRATION 2015-2024 ($ MILLION)

43.   ASIA PACIFIC ALLERGY TREATMENT MARKET BY FORM OF ADMINISTRATION 2015-2024 ($ MILLION)

44.   REST OF THE WORLD ALLERGY TREATMENT MARKET BY FORM OF ADMINISTRATION 2015-2024 ($ MILLION)

45.   NORTH AMERICA ALLERGY TREATMENT MARKET BY TREATMENT PRODUCTS 2015-2024 ($ MILLION)

46.   EUROPE ALLERGY TREATMENT MARKET BY TREATMENT PRODUCTS 2015-2024 ($ MILLION)

47.   ASIA PACIFIC ALLERGY TREATMENT MARKET BY TREATMENT PRODUCTS 2015-2024 ($ MILLION)

48.   REST OF THE WORLD ALLERGY TREATMENT MARKET BY TREATMENT PRODUCTS 2015-2024 ($ MILLION)

49.   UNITED STATES ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

50.   UNITED STATES ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

51.   CANADA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

52.   CANADA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

53.   UK ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

54.   UK ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

55.   FRANCE ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

56.   FRANCE ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

57.   GERMANY ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

58.   GERMANY ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

59.   SPAIN ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

60.   SPAIN ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

61.   ROE ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

62.   ROE ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

63.   CHINA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

64.   CHINA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

65.   INDIA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

66.   INDIA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

67.   JAPAN ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

68.   JAPAN ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

69.   AUSTRALIA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

70.   AUSTRALIA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

71.   ROAPAC ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

72.   ROAPAC ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

73.   LATIN AMERICA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

74.   LATIN AMERICA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

75.   MENA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

76.   MENA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

 

LIST OF FIGURES

1.       GLOBAL DIAGNOSTICS MARKET 2015-2024 ($ MILLION)

2.       GLOBAL TREATMENT  MARKET 2015-2024 ($ MILLION)

3.       GLOBAL  IMMUNOTHERAPY MARKET  2015-2024 ($ MILLION)

4.       GLOBAL SKIN PRICK, PATCH INTRADERMAL TEST MARKET 2015-2024 ($ MILLION)

5.       GLOBAL ANTIBODY MARKET 2015-2024 ($ MILLION)

6.       GLOBAL  PRESCRIPTION MARKET  2015-2024 ($ MILLION)

7.       GLOBAL GENERIC MARKET 2015-2024 ($ MILLION)

8.       GLOBAL OTC MARKET 2015-2024 ($ MILLION)

9.       GLOBAL ORAL MARKET   2015-2024 ($ MILLION)

10.   GLOBAL  TOPICAL MARKET   2015-2024 ($ MILLION)

11.   GLOBAL SPRAY MARKET   2015-2024 ($ MILLION)

12.   GLOBAL  OCULAR MARKET   2015-2024 ($ MILLION)

13.   GLOBAL  ANTIHISTAMINES  MARKET   2015-2024 ($ MILLION)

14.   GLOBAL SYMPATHOMIMETICS DECONGESTANTS AND COMBINATIONS  MARKET   2015-2024 ($ MILLION)

15.   GLOBAL  CORTICOSTEROIDS MARKET   2015-2024 ($ MILLION)

16.   GLOBAL LEUKOTRIENES MARKET   2015-2024 ($ MILLION)

17.   GLOBAL  MAST CELL STABILIZERS MARKET  2015-2024 ($ MILLION)

18.   UNITED STATES (U.S.) ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET 2015-2024 ($ MILLION)

19.   CANADA ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET 2015-2024 ($ MILLION)

20.   UNITED KINGDOM (UK) ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

21.   FRANCE ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET 2015-2024 ($ MILLION)

22.   GERMANY ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

23.   SPAIN ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

24.   ROE ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

25.   INDIA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

26.   CHINA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

27.   JAPAN ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

28.   AUSTRALIA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

29.   ROAPAC ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

30.   LATIN AMERICA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

31.   MENA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION) 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Diagnostics » HME-1491015
  • Global Allergy Diagnostics and Treatments Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Publish: November 2016 | Report Code: HME-1491015

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Global Allergy Diagnostics and treatment market is expected to have the CAGR of 12.67% in the forecast period 2016-2023.  The major factors driving the global allergy diagnostics and treatment market are increasing number of allergies, rising IVD market, increasing healthcare expenditure and increasing laboratory automation. Increasing respiratory allergic cases day by day has increased the market of allergy diagnostics and treatment. According to American Academy of Allergy Asthma and Immunology (AAAAI), in 2016, around 7.8 million children suffered from respiratory allergies worldwide. Food allergies and eczema are the most common chronic non-communicable diseases in children in several countries. The adoption of allergy diagnostics and treatment in global allergy diagnostics and treatment market is driven by following factors:

  • Increasing Allergies
  • Growing IVD Market
  • Increasing Healthcare Expenditure
  • Increasing Laboratory Automation





Increasing strict regulations for the approval and use of the medial devices is the major factor hindering the growth of allergy diagnostics and treatment market. Regulations are formulated to strengthen the supervision, administration of medical devices and ensuring their safety and effectiveness and protection against human health and life safety. The medical devices are defined by the regulations which refer to any material, appliance, apparatus, instrument or other article whether used alone or in combination, including software which is used in that proper application. It does not achieve its principal action in or on the human body by means of metabolism, immunology or pharmacology. Approval for the trial of new devices from any of the relevant authority is quite compulsory so as to use the product. The drug regulatory authorities of government appoint medical device monitors in their organization, who are responsible for the supervision of medical device manufacturing enterprises, distribution enterprises and medical institutions within their own administrative regions.   In the case when the medical devices are manufactured without any product registration certificates, then the drug regulatory authority of government shall issue an order to stop the production, confiscate all the illegal manufactured products and related illegal income.

Source: OBRC Analysis

Global allergy diagnostics and treatment market is majorly segmented on the basis of types, product and end users. On the basis of types, the allergy diagnostics and treatment market is further segmented as:

  • Food
  • Inhaled
  • Others




On the basis of product, the allergy diagnostics and treatment market is further segmented as:

  • Assay Kits
  • Consumables
  • Instruments



On the basis of end users, the allergy diagnostics and treatment market is further segmented as:

  • Academic Research Centres
  • Diagnostic Laboratories
  • Hospitals
  • Other





The revenue for the above types, products and end-user segment are specific to the allergy diagnostics and treatment market. However, the total revenue of these products, type and end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up product, type and end-user segment.

Geographically, global allergy diagnostics and treatments market is segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America holds the largest market share of allergy diagnostics and treatment and is followed by Europe. High technology and high investments in medical sector is helping the market to grow. In addition to this, every thirteen children of age 18 years in U.S. suffers from at least one of the allergic problems. In Europe, there are more than 17 million cases of food allergy and there has been a seven times increase among children over the past decades. Moreover, Asian Pacific market is expected to rise rapidly at a high CAGR in the forecast period, due to the rapid increase in the geriatric population, and large untapped potential of these markets. However, based on end user segment, hospitals dominates the market and it is expected to grow in the future.

The major market players of the global allergy diagnostics and treatment market are:

  • ALLERCHECK LABORATORIES INC.
  • BIOMERIEUX SA
  • DANAHER CORPORATION
  • STALLERGENES
  • OTHERS






Detailed analysis of these companies provided in this report comprises of overview, SCOT analysis, product portfolio, strategic initiative and strategic analysis.

These companies use various strategies such as merger & acquisition, collaboration, partnership and product launching. Acquisitions and mergers are the key strategies adopted by the market players to sustain in the market. For example: MeDALL allergen chip is used to determine allergies which enhance allergy diagnostics and treatment market globally. In Japan 2015, Stallergenes received approval for STG 320 which is the first tablet used in the treatment of allergies against house dust mite.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as acquisition that is on April 2016, Siemens Healthcare acquires San-Francisco based company Medicalis Corporation so as expand the tools it can offer health systems and hospitals to manage value-based care.
  • Provide in detail the different segments such as products and end-users which affect the global allergy diagnostics and treatment market.
  • Provide you the patent analysis of global allergy diagnostics and treatment market.
  • Identify and understand the strengths, opportunities, challenges and threats of global allergy diagnostics and treatment market.
  • Provide revenues of major players of the market such as Danaher Corporation and Hitachi Chemical Diagnostics, Inc.
  • Provide you various regulatory policies which affect the global allergy diagnostics and treatment market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global allergy diagnostics and treatment market offers the longest chain of market segmentation covering major market segmentation based on products and end users. The report tracks the major market trends in the global allergy diagnostics and treatmentmarket such as rising availability of effective treatment options.   For each market segments covered in global allergy diagnostics and treatment market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the allergy diagnostics and treatment industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, see saw analysis, and porter five force model and so on. For the high-level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global allergy diagnostics and treatment market:

  • North America had the largest revenue share in 2016.
  • Based on product Assay Kit dominates the market.
  • Acquisition is the key strategy adopted by the various market players of global allergy diagnostics and treatment market.
  • Hospital is the major segment of end user.

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL  ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET : EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1.        TOP 5 FINDINGS

2.5.2.        TOP 5 OPPORTUNITY MARKETS

2.5.3.        TOP 5 COMPANIES

2.5.4.        TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1.        INVESTMENT VS. ADOPTION MODEL

2.7.2.        360-DEGREE INDUSTRY ANALYSIS

2.7.3.        PORTERS 5 FORCE MODEL

2.7.4.        SEE-SAW ANALYSIS

2.7.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1.        KEY STRATEGIES & ANALYSIS

2.8.2.        MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        INCREASING PREVALENCE OF ALLERGIC DISEASES

3.1.2.        GROWING IVD MARKET

3.1.3.        INCREASING HEALTHCARE EXPENDITURE

3.1.4.        INCREASING ACCESS FOR ALLERGY DIAGNOSIS MEDICAL INSURANCE IN THE US

3.2. MARKET RESTRAINTS

3.2.1.        LOW AWARENESS OF ALLERGIC DISEASES

3.2.2.        AFFORDABILITY ISSUES OF ALLERGY DIAGNOSTICS INSTRUMENTS

3.3. MARKET OPPORTUNITIES

3.3.1.        INCREASING OPPORTUNITIES IN DEVELOPING COUNTRIES

3.4.   MARKET CHALLENGES

3.4.1.        HIGH TURNAROUND TIME

3.4.2.        GROWTH IN THE NUMBER OF REAGENT RENTAL AGREEMENTS

4.      GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.  OPPORTUNITY MATRIX

4.5. MARKET SEGMENTATION

4.5.1.      GLOBAL DIAGNOSTICS MARKET

4.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3.  KEY PLAYERS & KEY PRODUCTS

4.5.1.4.  KEY CONCLUSIONS

4.5.2.      GLOBAL TREATMENT MARKET

4.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3.  KEY PLAYERS & KEY PRODUCTS

4.5.2.4.  KEY CONCLUSIONS

4.5.3.      GLOBAL IMMUNOTHERAPY MARKET

4.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.3.3.  KEY PLAYERS & KEY PRODUCTS

4.5.3.4.  KEY CONCLUSIONS

5.      GLOBAL ALLERGY DIAGNOSTICS MARKET BY  TYPE

5.1. MARKET DEFINITION AND SCOPE

5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4.  OPPORTUNITY MATRIX

5.5. MARKET SEGMENTATION

5.5.1.      GLOBAL SKIN PRICK, PATCH INTRADERMAL TEST MARKET

5.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.3.  KEY PLAYERS & KEY PRODUCTS

5.5.1.4.  KEY CONCLUSIONS

5.5.2.      GLOBAL ANTIBODY MARKET

5.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3.  KEY PLAYERS & KEY PRODUCTS

5.5.2.4.  KEY CONCLUSIONS

6.      GLOBAL ALLERGY TREATMENT MARKET BY  TYPE

6.1. MARKET DEFINITION AND SCOPE

6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.4.  OPPORTUNITY MATRIX

6.5. MARKET SEGMENTATION

6.5.1.      GLOBAL PRESCRIPTION MARKET

6.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.1.3.  KEY PLAYERS & KEY PRODUCTS

6.5.1.4.  KEY CONCLUSIONS

6.5.2.      GLOBAL GENERIC MARKET

6.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.2.3.  KEY PLAYERS & KEY PRODUCTS

6.5.2.4.  KEY CONCLUSIONS

6.5.3.      GLOBAL OTC  MARKET

6.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.3.3.  KEY PLAYERS & KEY PRODUCTS

6.5.3.4.  KEY CONCLUSIONS

7.      GLOBAL ALLERGY TREATMENT MARKET BY FORM OF ADMINISTRATION

7.1. MARKET DEFINITION AND SCOPE

7.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

7.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

7.4.  OPPORTUNITY MATRIX

7.5. MARKET SEGMENTATION

7.5.1.      GLOBAL ORAL MARKET

7.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.5.1.3.  KEY PLAYERS & KEY PRODUCTS

7.5.1.4.  KEY CONCLUSIONS

7.5.2.      GLOBAL TOPICAL MARKET

7.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.5.2.3.  KEY PLAYERS & KEY PRODUCTS

7.5.2.4.  KEY CONCLUSIONS

7.5.3.      GLOBAL SPRAY MARKET

7.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.5.3.3.  KEY PLAYERS & KEY PRODUCTS

7.5.3.4.  KEY CONCLUSIONS

7.5.4.      GLOBAL OCULAR MARKET

7.5.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.5.4.3.  KEY PLAYERS & KEY PRODUCTS

7.5.4.4.  KEY CONCLUSIONS

8.      GLOBAL ALLERGY TREATMENT MARKET BY TREATMENT PRODUCTS

8.1. MARKET DEFINITION AND SCOPE

8.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

8.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

8.4.  OPPORTUNITY MATRIX

8.5. MARKET SEGMENTATION

8.5.1.      GLOBAL ANTIHISTAMINES  MARKET

8.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.1.3.  KEY PLAYERS & KEY PRODUCTS

8.5.1.4.  KEY CONCLUSIONS

8.5.2.      GLOBAL SYMPATHOMIMETICS DECONGESTANTS AND COMBINATIONS MARKET

8.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.2.3.  KEY PLAYERS & KEY PRODUCTS

8.5.2.4.  KEY CONCLUSIONS

8.5.3.      GLOBAL CORTICOSTEROIDS MARKET

8.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.3.3.  KEY PLAYERS & KEY PRODUCTS

8.5.3.4.  KEY CONCLUSIONS

8.5.4.      GLOBAL LEUKOTRIENESMARKET

8.5.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.4.3.  KEY PLAYERS & KEY PRODUCTS

8.5.4.4.  KEY CONCLUSIONS

8.5.5.      GLOBAL MAST CELL STABILIZERS MARKET

8.5.5.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.5.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.5.3.  KEY PLAYERS & KEY PRODUCTS

8.5.5.4.  KEY CONCLUSIONS

9.      GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  STAKEHOLDERS

9.1. MARKET DEFINITION AND SCOPE

9.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

9.3. MARKET SEGMENTATION

9.3.1.      GLOBAL RETAILERS MARKET

9.3.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

9.3.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.3.2.      GLOBAL RAW MATERIAL SUPPLIER MARKET

9.3.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

9.3.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.3.3.      GLOBAL MANUFACTURER MARKET

9.3.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

9.3.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.3.4.      GLOBAL DISTRIBUTOR AND LOGISTICS MARKET

9.3.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

9.3.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.   COMPETITIVE LANDSCAPE

10.1.                  KEY STRATEGIES

10.1.1.   LIST OF MERGERS AND ACQUISITION

10.1.2.   LIST OF JOINT VENTURES

10.1.3.   LIST OF PRODUCT LAUNCHES

10.1.4.   LIST OF PARTNERSHIPS

11.   GEOGRAPHIC ANALYSIS

11.1.                  DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

11.2.                  COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

11.3.                  OPPORTUNITY MATRIX

11.4.                  GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY REGION 2015-2024 ($ MILLION)

11.4.1.  NORTH AMERICA

11.4.1.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

11.4.1.2.                      TOP COUNTRY ANALYSIS

11.4.1.2.1.  U.S.

11.4.1.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.1.2.1.2.           KEY PLAYERS & KEY PRODUCTS

11.4.1.2.1.3.           KEY CONCLUSIONS

11.4.1.2.2.  CANADA

11.4.1.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.1.2.2.2.           KEY PLAYERS & KEY PRODUCTS

11.4.1.2.2.3.           KEY CONCLUSIONS

11.4.2.  EUROPE

11.4.2.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

11.4.2.2.                      TOP COUNTRY ANALYSIS

11.4.2.2.1.  UK

11.4.2.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.2.2.1.2.           KEY PLAYERS & KEY PRODUCTS

11.4.2.2.1.3.           KEY CONCLUSIONS

11.4.2.2.2.  FRANCE

11.4.2.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.2.2.2.2.           KEY PLAYERS & KEY PRODUCTS

11.4.2.2.2.3.           KEY CONCLUSIONS

11.4.2.2.3.  GERMANY

11.4.2.2.3.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.2.2.3.2.           KEY PLAYERS & KEY PRODUCTS

11.4.2.2.3.3.           KEY CONCLUSIONS

11.4.2.2.4.  SPAIN

11.4.2.2.4.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.2.2.4.2.           KEY PLAYERS & KEY PRODUCTS

11.4.2.2.4.3.           KEY CONCLUSIONS

11.4.2.2.5.  REST OF EUROPE

11.4.2.2.5.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.2.2.5.2.           KEY  PLAYERS & KEY PRODUCTS

11.4.2.2.5.3.           KEY CONCLUSIONS

11.4.3.  ASIA PACIFIC

11.4.3.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

11.4.3.2.                      TOP COUNTRY ANALYSIS

11.4.3.2.1.  CHINA

11.4.3.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.3.2.1.2.           KEY PLAYERS & KEY PRODUCTS

11.4.3.2.1.3.           KEY CONCLUSIONS

11.4.3.2.2.  INDIA

11.4.3.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.3.2.2.2.           KEY PLAYERS & KEY PRODUCTS

11.4.3.2.2.3.           KEY CONCLUSIONS

11.4.3.2.3.  JAPAN

11.4.3.2.3.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.3.2.3.2.           KEY PLAYERS & KEY PRODUCTS

11.4.3.2.3.3.           KEY CONCLUSIONS

11.4.3.2.4.  AUSTRALIA

11.4.3.2.4.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.3.2.4.2.           KEY  PLAYERS & KEY PRODUCTS

11.4.3.2.4.3.           KEY CONCLUSIONS

11.4.3.2.5.  REST OF ASIA PACIFIC

11.4.3.2.5.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.3.2.5.2.           KEY  PLAYERS & KEY PRODUCTS

11.4.3.2.5.3.           KEY CONCLUSIONS

11.4.4.  ROW

11.4.4.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

11.4.4.2.                      TOP COUNTRY ANALYSIS

11.4.4.2.1.  LATIN AMERICA

11.4.4.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.4.2.1.2.           KEY PLAYERS & KEY PRODUCTS

11.4.4.2.1.3.           KEY CONCLUSIONS

11.4.4.2.2.  MIDDLE EAST & AFRICA

11.4.4.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

11.4.4.2.2.2.           KEY PLAYERS & KEY PRODUCTS

11.4.4.2.2.3.           KEY CONCLUSIONS

12.   COMPANY PROFILES

12.1.                  ALCON LABORATORIES (U.S.)

12.1.1.   OVERVIEW

12.1.2.   PRODUCT PORTFOLIO

12.1.3.   STRATEGIC INITIATIVES

12.1.4.   SCOT ANALYSIS

12.1.5.   STRATEGIC ANALYSIS

12.2.                  ALERCHECK, INC. (U.S.)

12.2.1.   OVERVIEW

12.2.2.   PRODUCT PORTFOLIO

12.2.3.   STRATEGIC INITIATIVES

12.2.4.   SCOT ANALYSIS

12.2.5.   STRATEGIC ANALYSIS

12.3.                  ASTRA BIOTECH (GERMANY)

12.3.1.   OVERVIEW

12.3.2.   PRODUCT PORTFOLIO

12.3.3.   STRATEGIC INITIATIVES

12.3.4.   SCOT ANALYSIS

12.3.5.   STRATEGIC ANALYSIS

12.4.                  BIOMERIEUX (FRANCE)

12.4.1.   OVERVIEW

12.4.2.   PRODUCT PORTFOLIO

12.4.3.   STRATEGIC INITIATIVES

12.4.4.   SCOT ANALYSIS

12.4.5.   STRATEGIC ANALYSIS

12.5.                  DANAHER CORPORATION (U.S.)

12.5.1.   OVERVIEW

12.5.2.   PRODUCT PORTFOLIO

12.5.3.   STRATEGIC INITIATIVES

12.5.4.   SCOT ANALYSIS

12.5.5.   STRATEGIC ANALYSIS

12.6.                  HITACHI CHEMICAL DIAGNOSTICS (U.S.)

12.6.1.   OVERVIEW

12.6.2.   PRODUCT PORTFOLIO

12.6.3.   STRATEGIC INITIATIVES

12.6.4.   SCOT ANALYSIS

12.6.5.   STRATEGIC ANALYSIS

12.7.                  HOB BIOTECH GROUP (CHINA)

12.7.1.   OVERVIEW

12.7.2.   PRODUCT PORTFOLIO

12.7.3.   STRATEGIC INITIATIVES

12.7.4.   SCOT ANALYSIS

12.7.5.   STRATEGIC ANALYSIS

12.8.                  HYCOR BIOMEDICAL (U.S.)

12.8.1.   OVERVIEW

12.8.2.   PRODUCT PORTFOLIO

12.8.3.   STRATEGIC INITIATIVES

12.8.4.   SCOT ANALYSIS

12.8.5.   STRATEGIC ANALYSIS

12.9.                  LINCOLN DIAGNOSTICS (U.S.)

12.9.1.   OVERVIEW

12.9.2.   PRODUCT PORTFOLIO

12.9.3.   STRATEGIC INITIATIVES

12.9.4.   SCOT ANALYSIS

12.9.5.   STRATEGIC ANALYSIS

12.10.              OMEGA DIAGNOSTICS (UK)

12.10.1.                       OVERVIEW

12.10.2.                       PRODUCT PORTFOLIO

12.10.3.                       STRATEGIC INITIATIVES

12.10.4.                       SCOT ANALYSIS

12.10.5.                       STRATEGIC ANALYSIS

12.11.              R-BIOPHARM AG (GERMANY)

12.11.1.                       OVERVIEW

12.11.2.                       PRODUCT PORTFOLIO

12.11.3.                       STRATEGIC INITIATIVES

12.11.4.                       SCOT ANALYSIS

12.11.5.                       STRATEGIC ANALYSIS

12.12.              SANOFI S.A (FRANCE)

12.12.1.                       OVERVIEW

12.12.2.                       PRODUCT PORTFOLIO

12.12.3.                       STRATEGIC INITIATIVES

12.12.4.                       SCOT ANALYSIS

12.12.5.                       STRATEGIC ANALYSIS

12.13.              SIEMENS HEALTHCARE (GERMANY)

12.13.1.                       OVERVIEW

12.13.2.                       PRODUCT PORTFOLIO

12.13.3.                       STRATEGIC INITIATIVES

12.13.4.                       SCOT ANALYSIS

12.13.5.                       STRATEGIC ANALYSIS

12.14.              STALLERGENES (UK)

12.14.1.                       OVERVIEW

12.14.2.                       PRODUCT PORTFOLIO

12.14.3.                       STRATEGIC INITIATIVES

12.14.4.                       SCOT ANALYSIS

12.14.5.                       STRATEGIC ANALYSIS

12.15.              THERMO FISHER SCIENTIFIC (U.S.)

12.15.1.                       OVERVIEW

12.15.2.                       PRODUCT PORTFOLIO

12.15.3.                       STRATEGIC INITIATIVES

12.15.4.                       SCOT ANALYSIS

12.15.5.                       STRATEGIC ANALYSIS

LIST OF TABLES

1.       GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY TYPE  2015-2024 ($ MILLION)

2.       GLOBAL DIAGNOSTICS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL TREATMENT  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL  IMMUNOTHERAPY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5.       GLOBAL ALLERGY DIAGNOSTICS MARKET BY TYPE  2015-2024 ($ MILLION)

6.       GLOBAL SKIN PRICK, PATCH INTRADERMAL TEST MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

7.       GLOBAL ANTIBODY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

8.       GLOBAL ALLERGY TREATMENTS MARKET BY TYPE  2015-2024 ($ MILLION)

9.       GLOBAL  PRESCRIPTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL GENERIC MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL OTC MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

12.   GLOBAL ALLERGY TREATMENTS MARKET BY FORM OF ADMINISTRATION 2015-2024 ($ MILLION)

13.   GLOBAL ORAL MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

14.   GLOBAL  TOPICAL MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

15.   GLOBAL SPRAY MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

16.   GLOBAL  OCULAR MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

17.   GLOBAL ALLERGY TREATMENTS MARKET BY TREATMENT PRODUCTS 2015-2024 ($ MILLION)

18.   GLOBAL  ANTIHISTAMINES  MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

19.   GLOBAL SYMPATHOMIMETICS DECONGESTANTS AND COMBINATIONS  MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

20.   GLOBAL  CORTICOSTEROIDS MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

21.   GLOBAL LEUKOTRIENES MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

22.   GLOBAL  MAST CELL STABILIZERS MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

23.   GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY STAKEHOLDERS 2015-2024 ($ MILLION)

24.   GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

25.   NORTH AMERICA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

26.   EUROPE ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET 2015-2024 ($ MILLION)

27.   ASIA PACIFIC ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

28.   REST OF THE WORLD ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

29.   NORTH AMERICA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

30.   EUROPE ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET BY  TYPE 2015-2024 ($ MILLION)

31.   ASIA PACIFIC ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

32.   REST OF THE WORLD ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

33.   NORTH AMERICA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

34.   EUROPE ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

35.   ASIA PACIFIC ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

36.   REST OF THE WORLD ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

37.   NORTH AMERICA ALLERGY TREATMENT MARKET BY  TYPE 2015-2024 ($ MILLION)

38.   EUROPE ALLERGY TREATMENT MARKET BY  TYPE 2015-2024 ($ MILLION)

39.   ASIA PACIFIC ALLERGY TREATMENT MARKET BY  TYPE 2015-2024 ($ MILLION)

40.   REST OF THE WORLD ALLERGY TREATMENT MARKET BY  TYPE 2015-2024 ($ MILLION)

41.   NORTH AMERICA ALLERGY TREATMENT MARKET BY FORM OF ADMINISTRATION 2015-2024 ($ MILLION)

42.   EUROPE ALLERGY TREATMENT MARKET BY FORM OF ADMINISTRATION 2015-2024 ($ MILLION)

43.   ASIA PACIFIC ALLERGY TREATMENT MARKET BY FORM OF ADMINISTRATION 2015-2024 ($ MILLION)

44.   REST OF THE WORLD ALLERGY TREATMENT MARKET BY FORM OF ADMINISTRATION 2015-2024 ($ MILLION)

45.   NORTH AMERICA ALLERGY TREATMENT MARKET BY TREATMENT PRODUCTS 2015-2024 ($ MILLION)

46.   EUROPE ALLERGY TREATMENT MARKET BY TREATMENT PRODUCTS 2015-2024 ($ MILLION)

47.   ASIA PACIFIC ALLERGY TREATMENT MARKET BY TREATMENT PRODUCTS 2015-2024 ($ MILLION)

48.   REST OF THE WORLD ALLERGY TREATMENT MARKET BY TREATMENT PRODUCTS 2015-2024 ($ MILLION)

49.   UNITED STATES ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

50.   UNITED STATES ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

51.   CANADA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

52.   CANADA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

53.   UK ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

54.   UK ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

55.   FRANCE ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

56.   FRANCE ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

57.   GERMANY ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

58.   GERMANY ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

59.   SPAIN ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

60.   SPAIN ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

61.   ROE ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

62.   ROE ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

63.   CHINA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

64.   CHINA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

65.   INDIA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

66.   INDIA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

67.   JAPAN ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

68.   JAPAN ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

69.   AUSTRALIA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

70.   AUSTRALIA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

71.   ROAPAC ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

72.   ROAPAC ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

73.   LATIN AMERICA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

74.   LATIN AMERICA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

75.   MENA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY  TYPE 2015-2024 ($ MILLION)

76.   MENA ALLERGY DIAGNOSTICS MARKET BY  TYPE 2015-2024 ($ MILLION)

 

LIST OF FIGURES

1.       GLOBAL DIAGNOSTICS MARKET 2015-2024 ($ MILLION)

2.       GLOBAL TREATMENT  MARKET 2015-2024 ($ MILLION)

3.       GLOBAL  IMMUNOTHERAPY MARKET  2015-2024 ($ MILLION)

4.       GLOBAL SKIN PRICK, PATCH INTRADERMAL TEST MARKET 2015-2024 ($ MILLION)

5.       GLOBAL ANTIBODY MARKET 2015-2024 ($ MILLION)

6.       GLOBAL  PRESCRIPTION MARKET  2015-2024 ($ MILLION)

7.       GLOBAL GENERIC MARKET 2015-2024 ($ MILLION)

8.       GLOBAL OTC MARKET 2015-2024 ($ MILLION)

9.       GLOBAL ORAL MARKET   2015-2024 ($ MILLION)

10.   GLOBAL  TOPICAL MARKET   2015-2024 ($ MILLION)

11.   GLOBAL SPRAY MARKET   2015-2024 ($ MILLION)

12.   GLOBAL  OCULAR MARKET   2015-2024 ($ MILLION)

13.   GLOBAL  ANTIHISTAMINES  MARKET   2015-2024 ($ MILLION)

14.   GLOBAL SYMPATHOMIMETICS DECONGESTANTS AND COMBINATIONS  MARKET   2015-2024 ($ MILLION)

15.   GLOBAL  CORTICOSTEROIDS MARKET   2015-2024 ($ MILLION)

16.   GLOBAL LEUKOTRIENES MARKET   2015-2024 ($ MILLION)

17.   GLOBAL  MAST CELL STABILIZERS MARKET  2015-2024 ($ MILLION)

18.   UNITED STATES (U.S.) ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET 2015-2024 ($ MILLION)

19.   CANADA ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET 2015-2024 ($ MILLION)

20.   UNITED KINGDOM (UK) ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

21.   FRANCE ALLERGY DIAGNOSTICS AND TREATMENTS  MARKET 2015-2024 ($ MILLION)

22.   GERMANY ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

23.   SPAIN ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

24.   ROE ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

25.   INDIA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

26.   CHINA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

27.   JAPAN ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

28.   AUSTRALIA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

29.   ROAPAC ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

30.   LATIN AMERICA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION)

31.   MENA ALLERGY DIAGNOSTICS AND TREATMENTS MARKET 2015-2024 ($ MILLION) 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion